• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail

  • Print
  • Share
  • E-mail
Approval Date:  07/29/2008
Trade Name:  Cancidas
Generic or Proper Name (*):  caspofungin
Indications Studied:  Empirical therapy for presumed fungal infections in febrile, neutropenic patients; Candidemia and certain Candida infections; Esophageal Candidiasis; Invasive Aspergillosis in patients who are refractory to or intolerant of other therapies
Therapeutic Category:  Antifungal
Ages Studied:  0-3 months
Study #:  3
Study Type:  Safety/Pharmacokinetic/Tolerability (3/3)
Study Design:  Open Label/Traditional Pharmacokinetic
No Patients:  18
No Centers:  8
No Countries:  5